Background Proteomic biomarkers have shown promise in predicting various cardiovascular conditions, but their utility in assessing the risk of atrial fibrillation (AF) remains unclear. This study ...
Correspondence to Dr Niket Patel, Cardiology Department, Royal Free Hospital, Pond Street, London NW3 2QG, UK; niketpatel{at}nhs.net To understand the evolution in the strategies for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results